Lv2
150 积分 2025-05-08 加入
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
2个月前
已完结
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
2个月前
已关闭
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
2个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
2个月前
已完结
皖公网安备34019202002308
